Miglitol

Miglitol

SCHEMBL9207953

OCCN1C[C@H](O)[C@@H](O)[C@@H](O)C1CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GAAMGAM

The experimentally established mechanism targets of Miglitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 9/20 1.00
MGAM known ✓ O43451 3/20 1.00
GBA1 P04062 5/20 1.00
SI P14410 3/20 1.00
TDP1 Q9NUW8 1/20 1.00
LCT P09848 1/20 1.00
AGL P35573 3/20 0.88
GBA2 Q9HCG7 13/20 0.68
UGCG Q16739 3/20 0.68
MEN1 O00255 1/20 0.66
LMNA P02545 1/20 0.66
MAPK1 P28482 1/20 0.66
KMT2A Q03164 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Miglitol SCHEMBL15669407 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL7862967 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL5727959 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL20402709 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL6545551 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL23892585 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL15269512 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL682218 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL22593 1.00 GAA (1.00) GAAGBA1MGAMSITDP1
Miglitol SCHEMBL25887976 1.00 GAA (1.00) GAAGBA1MGAMSITDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0425929-B1 Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates BAYER AG (DE) 1995-12-06 EP disclosed
US-5071990-A PREPARATION OF INTERMEDIATES AND THE SYNTHESIS OF N-(2-HYDROXYETHYL)-2-HYDROXYMETHYL-3,4,5-TRIHYDROXYPIPERIDINES BAYER AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed
EP-0425929-A1 Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates BAYER AG (DE) 1991-05-08 EP disclosed